SCHEMBL26552175

SCHEMBL26552175

CC(C)Nc1cc(-c2ccccn2)[nH]n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.48
CCNB2 O95067 1/20 0.42
CDK1 P06493 1/20 0.42
CCNB1 P14635 1/20 0.42
GSK3B P49841 1/20 0.42
CDK5 Q00535 1/20 0.42
CDK5R1 Q15078 1/20 0.42
CCNB3 Q8WWL7 1/20 0.42
LMNA P02545 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
TRPM8 Q7Z2W7 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
MAPT P10636 2/20 0.40
MITF O75030 1/20 0.40
FFAR1 O14842 1/20 0.40
KDM4E B2RXH2 2/20 0.38
METAP1 P53582 2/20 0.38
POLB P06746 1/20 0.38
CCR1 P32246 1/20 0.38
CCR5 P51681 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26551636 0.80 CCNB2 (0.43) CYP1A2CCNB2CDK1CCNB1GSK3B
SCHEMBL13312330 0.78 APP (0.50) CYP1A2CCNB2CDK1CCNB1GSK3B
SCHEMBL25431149 0.78 RAB9A (0.53) LMNASMN1; SMN2L3MBTL1MAPTKDM4E
SCHEMBL26550441 0.77 RAB9A (0.43) CYP1A2CCNB2CDK1CCNB1GSK3B
SCHEMBL11965498 0.76 LRRK2 (0.42) CYP1A2CCNB2CDK1CCNB1GSK3B
SCHEMBL2623420 0.74 KDM4E (0.46) CYP1A2CCNB2CDK1CCNB1GSK3B
SCHEMBL12890236 0.73 CDK5 (0.38) CYP1A2CCNB2CDK1CCNB1GSK3B
SCHEMBL29376325 0.73 PIN1 (0.57) CYP1A2CCNB2CDK1CCNB1GSK3B
SCHEMBL1528433 0.73 PIN1 (0.57) CYP1A2CCNB2CDK1CCNB1GSK3B
SCHEMBL26547901 0.73 ROCK2 (0.46) LMNASMN1; SMN2MAPTKDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023196975-A1 COMPOUNDS THAT INTERACT WITH RAS SUPERFAMILY PROTEINS FOR TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE SHY THERAPEUTICS, LLC (US) 2023-10-12 WO disclosed